Immunome Stock Volatility Indicators Average True Range

IMNM Stock  USD 11.53  0.38  3.41%   
Immunome volatility indicators tool provides the execution environment for running the Average True Range indicator and other technical functions against Immunome. Immunome value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volatility indicators indicators. As with most other technical indicators, the Average True Range indicator function is designed to identify and follow existing trends. Immunome volatility indicators enable investors to predict price movements based on how different True Range indicators change over time. Please specify Time Period to run this model.

Indicator
Time Period
Execute Indicator
The output start index for this execution was four with a total number of output elements of fifty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Immunome volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Immunome Technical Analysis Modules

Most technical analysis of Immunome help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunome from various momentum indicators to cycle indicators. When you analyze Immunome charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Immunome Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Immunome. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immunome based on widely used predictive technical indicators. In general, we focus on analyzing Immunome Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immunome's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Immunome's intrinsic value. In addition to deriving basic predictive indicators for Immunome, we also check how macroeconomic factors affect Immunome price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Current Ratio5.823.096.634.38
Net Debt To EBITDA2.040.553.433.6
Hype
Prediction
LowEstimatedHigh
7.2811.5915.90
Details
Intrinsic
Valuation
LowRealHigh
4.598.9013.21
Details
Naive
Forecast
LowNextHigh
6.6010.9115.22
Details
7 Analysts
Consensus
LowTargetHigh
7.288.008.88
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Piotroski F Score Now

   

Piotroski F Score

Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Investor Favorites Idea
Investor Favorites
Invested over 40 shares
Momentum Idea
Momentum
Invested over 40 shares
Cash Cows Idea
Cash Cows
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Impulse Idea
Impulse
Invested over 100 shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Business Services Idea
Business Services
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
When determining whether Immunome is a strong investment it is important to analyze Immunome's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Immunome's future performance. For an informed investment choice regarding Immunome Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunome. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunome. If investors know Immunome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunome listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.94)
Revenue Per Share
0.189
Quarterly Revenue Growth
(0.18)
Return On Assets
(0.40)
Return On Equity
(2.76)
The market value of Immunome is measured differently than its book value, which is the value of Immunome that is recorded on the company's balance sheet. Investors also form their own opinion of Immunome's value that differs from its market value or its book value, called intrinsic value, which is Immunome's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunome's market value can be influenced by many factors that don't directly affect Immunome's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunome's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.